VibeOne Commercial Assessment

Challenges in the current process
It's slow
Building a revenue and NPV model by hand takes weeks. Deal terms can't be tested in real time.
It's fragmented
Assumptions and comparable programs are spread across sources, so models are hard to compare.
Forecasts are unreliable
Forecasting and NPV are imperfect. Development costs and timelines are unclear.
Faster answers, in one place, on your terms
Answers in minutes, not months
Model revenue and NPV, and test deal terms, without weeks of manual work.
Every assumption sourced
Every assumption in one model, pre-filled with its source and a confidence rating.
AI-PTRS with NPV
Model probability of technical and regulatory success alongside economic value.
Compared on the same terms
See how each asset stacks up against its closest competitors on trial design, patients, endpoints and safety.
Every assumption sourced, every program compared
See the revenue curve and risk-adjusted value, with every assumption pre-filled from its source and rated for confidence.
88+ competing programs modeled on one set of terms
Investment partner with its own clinical development team.
The partner needed to know how its asset compared with every competing program.
VibeOne modeled every rival program on the same terms: trial design, patients, endpoints and safety.
The partner got a clear view of where the field is crowded, which routes reach patients faster and which partners to approach.